Reporting owner · Q3 2026 · CIK 1577014

Rhodes Jason P: insider trades.

Rhodes Jason P reported 16 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 16 sales ($83.0M), across 1 company.

Transactions
16
Purchases (P)
0
Sales (S)
16
Companies
1
Name as filed
Rhodes Jason P

Companies

CompanyRelationshipTransactions
Dyne Therapeutics, Inc. (DYN)Director16

Transactions

16 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-14Dyne Therapeutics, Inc.S1,359,674$252,441,454Form 4
2026-08-14Dyne Therapeutics, Inc.S478,377$25567,358Form 4
2026-08-14Dyne Therapeutics, Inc.S322,465$25428,946Form 4
2026-08-13Dyne Therapeutics, Inc.S268,354$26.23,801,128Form 4
2026-08-13Dyne Therapeutics, Inc.S94,415$26.21,045,735Form 4
2026-08-13Dyne Therapeutics, Inc.S63,643$26.2751,411Form 4
2026-07-07Dyne Therapeutics, Inc.S62,543$23.171,154,994Form 4
2026-07-07Dyne Therapeutics, Inc.S14,844$23.621,140,150Form 4
2026-07-07Dyne Therapeutics, Inc.S49,193$23.17826,719Form 4
2026-07-07Dyne Therapeutics, Inc.S11,665$23.62815,054Form 4
2026-07-07Dyne Therapeutics, Inc.S29,587$23.624,069,482Form 4
2026-07-07Dyne Therapeutics, Inc.S124,379$23.174,099,069Form 4
2026-07-07Dyne Therapeutics, Inc.S5,000$23.612,962Form 4
2026-07-06Dyne Therapeutics, Inc.S127,182$22.791,217,537Form 4
2026-07-06Dyne Therapeutics, Inc.S253,039$22.794,223,448Form 4
2026-07-06Dyne Therapeutics, Inc.S100,019$22.79875,912Form 4

Questions

What stock did Rhodes Jason P buy or sell?

Rhodes Jason P reported 16 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 16 sales ($83.0M), across 1 company.

Is Rhodes Jason P the same person as other filers with this name?

This page covers SEC CIK 1577014 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/rhodes-jason-p-1577014.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.